Wuhan Keqian Biology Co.,Ltd (SHA:688526)

China flag China · Delayed Price · Currency is CNY
16.23
-0.16 (-0.98%)
At close: Feb 13, 2026
Market Cap7.53B +24.7%
Revenue (ttm)1.01B +12.4%
Net Income459.54M +53.6%
EPS0.98 +52.8%
Shares Out463.92M
PE Ratio16.57
Forward PE16.99
Dividend0.43 (2.65%)
Ex-Dividend DateJun 16, 2025
Volume1,896,163
Average Volume3,840,000
Open16.38
Previous Close16.39
Day's Range16.18 - 16.47
52-Week Range13.27 - 20.39
Beta0.55
RSI48.06
Earnings DateApr 8, 2026

About SHA:688526

Wuhan Keqian Biology Co.,Ltd focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China. The company offers vaccines for pigs, poultry, and pets, as well as diagnostic reagents. Wuhan Keqian Biology Co.,Ltd was founded in 2001 and is based in Wuhan, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 922
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688526
Full Company Profile

Financial Performance

In 2024, SHA:688526's revenue was 941.92 million, a decrease of -11.48% compared to the previous year's 1.06 billion. Earnings were 382.35 million, a decrease of -3.43%.

Financial Statements